Methods for Improving Respiratory System Health and Increasing the Concentration of Hypothiocyanate Ion in Vertebrate Lungs
AssigneeSynexis LLC
InventorJames D. LEE
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods and devices to improve respiratory system health, increase resistance to infection, and increase the hypothiocyanate ion in mammalian lungs. The methods generally comprise: generating a Hydrogen Peroxide Gas that is non-hydrated and free of ozone, and directing the gas comprising primarily Hydrogen Peroxide Gas into an environment and exposing a subject to the environment such that the Hydrogen Peroxide Gas acts to the increase of the hypothiocyanate ion in mammalian lungs.
Claims45
An enclosed space for human or veterinary use, said enclosed space comprising a therapeutic amount of purified hydrogen peroxide gas (PHPG) at a concentration of at least 0.01 parts per million for providing a dose of PHPG, wherein said PHPG is non-hydrated and free of ozone.
-8. (canceled)
A method for treating a respiratory illness in a subject in need thereof comprising:
- providing an environment comprising a purified hydrogen peroxide gas (PHPG) that is substantially free of hydration and ozone at a final concentration of at least 0.01 parts per million (ppm);
- and
- exposing said subject to said environment for at least one period of time to provide a therapeutic amount of PHPG, wherein said treating comprises reducing the severity of a respiratory infection, reducing the duration of a respiratory infection, reducing the severity of an allergy, preventing transmission of a respiratory infection, reducing transmission of a respiratory infection in a population, improving lung function, or any combination thereof.
-21. (canceled)
A method for controlling a pathogen in the respiratory system of a subject in need thereof comprising:
- generating a purified hydrogen peroxide gas (PHPG) that is substantially free of hydration and ozone to an environment, wherein said environment accumulates said PHPG at a final concentration of from about 0.02 ppm to about 0.05 ppm, and
- exposing said subject in need thereof to therapeutic amount said PHPG containing environment for a period of time to provide a dose of PHPG of at least 0.05 units of PHPG, wherein said pathogen is controlled in said subject.
(canceled)
(canceled)
(canceled)
-49. (canceled)
Dependencies are inferred from the claim text.